Skip to content
healthcare.dev

CARISOPRODOL

NDC 76420-646, CARISOPRODOL, tablet, from Asclemed USA, Inc..

Product NDC
76420-646
Status
Listed
Labeler
Asclemed USA, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203374
DEA schedule
CIV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76420-646 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARISOPRODOL350 mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
76420-646-0176420064601100 TABLET in 1 BOTTLE (76420-646-01)
76420-646-307642006463030 TABLET in 1 BOTTLE (76420-646-30)
76420-646-607642006466060 TABLET in 1 BOTTLE (76420-646-60)
76420-646-907642006469090 TABLET in 1 BOTTLE (76420-646-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4221d7d1-d7d6-46c4-be41-8c8e99129324

Use it

Look up 76420-646 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76420-646 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76420-646. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.